Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Sue C. Heffelfinger"'
Autor:
W. Kassing, Sawako Kato, M. Krishnamoorthy, Sue C. Heffelfinger, Murad Melhem, J. Zhang, Makoto Watanabe, George Tsirpanlis, A. Karpouza, Ingrid Linsberger, J. Janzen, Dieter Falkenhagen, Miguel C. Riella, Roberto Pecoits-Filho, Yuedong Wang, Burnett S. Kelly, Yi-sheng Shan, Mohamed E. Suliman, Tao Wang, Louise Nordfors, Xing-wei Zhe, Lei Cheng, Prabir Roy-Chaudhury, Jens Hartmann, Peter Bárány, Eirini Grapsa, Jonas Axelsson, Olof Heimbürger, Debora A. Grahl, Viktoria Weber, Abdul Rashid Qureshi, Peter Stenvinkel, E. Samouilidou, Pankaj B. Desai, Bengt Lindholm, Antonis Lagouranis, V. Mickley
Publikováno v:
Blood Purification. 25:183-208
Autor:
Sue C. Heffelfinger, Deborah J. Clegg
Publikováno v:
Women's Health. 2:577-585
Obesity is an increasing worldwide epidemic. With an increased prevalence of obesity there is an increase in obesity-related cancers, such as breast cancer. Although reproductive and lifestyle choices are among the best-recognized risk factors for br
Autor:
Rino Munda, Jinsong Li, Murad Melhem, Pankaj B. Desai, Sue C. Heffelfinger, Prabir Roy-Chaudhury, Jianhua Zhang, Burnett S. Kelly
Publikováno v:
Cardiology Clinics. 23:249-273
This article (1) identifies the types of hemodialysis access, (2) summarizes the clinical standard of care for dialysis access grafts and fistulae, (3) describes the pathology and pathogenesis of venous stenosis in dialysis access grafts and fistulae
Publikováno v:
Breast Cancer Research and Treatment. 90:65-70
Hormone responsive breast cancer is usually determined by the presence of estrogen receptors (ER) or progesterone receptors (PR) on primary invasive breast cancers. Adjuvant and metastatic hormone therapy are recommended based on primary ER and PR de
Autor:
Rino Munda, Jinsong Li, Pankaj B. Desai, Murad Melhem, Burnett S. Kelly, Prabir Roy-Chaudhury, Sue C. Heffelfinger, Jianhua Zhang
Publikováno v:
Blood Purification. 23:29-35
Hemodialysis vascular access dysfunction is a major cause of morbidity in the hemodialysis population and contributes significantly to the overall cost of end-stage renal disease programs. At a histological level, most hemodialysis vascular access dy
Autor:
Hyun I. Park, Sue C. Heffelfinger, Aizhen Xiao, Yun-Ge Zhao, Qing-Xiang Amy Sang, Yan-gao Man, Robert G. Newcomer, Mei Yan
Publikováno v:
Cancer Research. 64:590-598
Local disruption of the integrity of both the myoepithelial cell layer and the basement membrane is an indispensable prerequisite for the initiation of invasion and the conversion of human breast ductal carcinoma in situ (DCIS) to infiltrating ductal
Autor:
Mei Yan, Sue C. Heffelfinger, David Warshawsky, Joanne Schneider, Kathy LaDow, Robin B. Gear, Fengxian Lu
Publikováno v:
Pathobiology. 71:253-260
Objective: In the 7,12-dimethylbenz[a]anthracene (DMBA) model of rat mammary carcinogenesis, microvascular density and angiogenic potential increase with progression from normal to invasive disease, but the mechanisms involved are unknown. Using RT-P
Publikováno v:
Pediatric and Developmental Pathology. 6:484-494
Neuroendocrine cells (NEC) are abundant in fetal and neonatal lungs, but reduced in infants with hyaline membrane disease. Perinatal neuroendocrine cell hyperplasia (NCH) has been reported in the hypoplastic lung in diaphragmatic hernia, bronchopulmo
Autor:
Murad Melhem, Ashwath Narayana, Prabir Roy-Chaudhury, Sue C. Heffelfinger, Burnett S. Kelly, Jianhua Zhang, Heather J. Duncan, Pankaj B. Desai
Publikováno v:
Blood Purification. 21:99-110
Hemodialysis vascular access dysfunction is a major cause of morbidity and hospitalization in the hemodialysis population at a cost of over USD 1 billion per annum. Most hemodialysis grafts fail due to a venous stenosis (venous neointimal hyperplasia
Autor:
Nuwan Nanayakkara, Prabir Roy-Chaudhury, Mary Ann Miller, Howard R. Elson, Sue C. Heffelfinger, Janice Armstrong, Wendy Karle, Burnett S. Kelly, Ashwath Narayana, David Denman
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 54:263-269
Purpose : Hemodialysis vascular access dysfunction is an enormous clinical problem that causes great morbidity and costs well over one billion dollars per annum. The vast majority of hemodialysis vascular access dysfunction occurs as a result of veno